Decision letter for "Adverse Events Associated with Use of Immunoglobulin in Pediatric Patients Reported to the US Food and Drug Administration Adverse Event Reporting System, 2001 – 2023"

Publons reviews and discussion 2026

View at publisher

DOI: 10.1111/pai.70319/v2/decision1

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions Patient Safety and Medication Errors